TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

17.50$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Relay Therapeutics Inc (RLAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 967 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLAY
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
907 844 841 773 930 871 799 729 670 621 700 967
832 770 770 704 865 809 740 680 624 578 658 928
151 144 153 134 152 124 94 114 92 84 205 121
811 750 750 688 840 781 710 657 596 555 642 911
0.2 0.0 – – – – – – – – – –
17 – – – – – – – – – – –
2.3 2.3 2.3 2.3 2.3 2.3 2.3 – – – – –
129 92 96 91 91 94 78 63 62 54 57 77
51 30 37 45 47 51 37 33 33 26 30 51
4.8 5.0 5.1 5.3 5.5 5.7 5.9 3.5 3.6 3.8 3.9 4.0
13 9.2 8.0 11 6.9 14 8.5 5.2 2.8 7.7 4.1 11
778 752 746 682 839 778 721 666 608 567 642 890
-1,317 -1,401 -1,482 -1,574 -1,662 -1,738 -1,815 -1,886 -1,960 -2,015 -2,088 -2,172
122 123 131 133 140 167 169 171 172 172 180 203

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?